Mon-ACT: A Multi-center, Non-interventional Study in Rheumatoid Arthritis (RA) Patients Treated With Tocilizumab in Monotherapy
Phase of Trial: Phase IV
Latest Information Update: 11 Feb 2016
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms Mon-ACT
- Sponsors Roche
- 19 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 26 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 23 Dec 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Dec 2014 to 1 Jan 2015.